Format

Send to

Choose Destination
Prog Retin Eye Res. 2013 Nov;37:163-81. doi: 10.1016/j.preteyeres.2013.09.002. Epub 2013 Oct 6.

Using human induced pluripotent stem cells to treat retinal disease.

Author information

1
MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK; Ophthalmology, School of Clinical Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK.

Abstract

The eye is an ideal target for exploiting the potential of human induced pluripotent stem cell (hiPSC) technology in order to understand disease pathways and explore novel therapeutic strategies for inherited retinal disease. The aim of this article is to map the pathway from state-of-the art laboratory-based discoveries to realising the translational potential of this emerging technique. We describe the relevance and routes to establishing hiPSCs in selected models of human retinal disease. Additionally, we define pathways for applying hiPSC technology in treating currently incurable, progressive and blinding retinal disease.

KEYWORDS:

Pluripotent; Reprogramming; Retina; Stem cells; iPS

PMID:
24104210
PMCID:
PMC3841575
DOI:
10.1016/j.preteyeres.2013.09.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center